Lesson plan

Abionic

Abionic SA is a company specializing in the development of ultra-rapid in vitro diagnostic tests, based in Lausanne, Switzerland. Abionic has developed the , a point-of-care diagnostic platform using its patented nanofluidic technology. The is implemented in intensive care units and emergency departments to enable early identification of sepsis using a proprietary biomarker, Pancreatic Stone Protein (PSP). The is also used in primary care for screening for the iron deficiency, respiratory allergies, and more recently for COVID-19 screening with an antigenic saliva and nasopharyngeal test.

Back to article

Article summary

Abionic SA is a company specializing in the development of ultra-rapid in vitro diagnostic tests, based in Lausanne, Switzerland. Abionic has developed the , a point-of-care diagnostic platform using its patented nanofluidic technology. The is implemented in intensive care units and emergency departments to enable early identification of sepsis using a proprietary biomarker, Pancreatic Stone Protein (PSP). The is also used in primary care for screening for the iron deficiency, respiratory allergies, and more recently for COVID-19 screening with an antigenic saliva and nasopharyngeal test.

Key claims

  1. date of foundation: 2010 — source: Wikipedia · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of foundation is "2010". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

  1. Wikipedia https://en.wikipedia.org/w/index.php?oldid=1364040067

Key claims and bibliography are generated from the same tracked claims and sources as the article page.